FDA.reportPublic FDA data

NUVALU ICE THERAPY MENTHOL PAIN RELIEVING

Manufacturer
Ningbo Liyuan Daily Chemical Products Co., Ltd.
Effective date
2018-11-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:45:39

Label at a glance#

ProductNUVALU ICE THERAPY MENTHOL PAIN RELIEVING
Active ingredientMENTHOL
Label structure12 sections

Dosage and administration

Clean affected area before applying product Adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily

Label contents#

Full prescribing information#

Drug Facts Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Menthol 1.25 percent

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

USE:

DOSAGE & ADMINISTRATION SECTION

for the temporary relief of minor aches and pains in muscles and joints associated with:

simple backache, strains, sprains, sports injuries, arthritis, bruises

Warnings:

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • with other topical pain relievers
  • with heating pads or heating devices

When using this product

OTC - WHEN USING SECTION

  • Do not use in or near eyes
  • Do not apply to wounds or damaged skin
  • Do not bandage tightly

Stop use and ask doctor if

OTC - STOP USE SECTION

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days
  • redness or irritation develops

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Posion Control Center right away.

Directions:

INDICATIONS & USAGE SECTION

  • Clean affected area before applying product
  • Adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

Water (Aqua), Ethyl Alcohol, Camphor, Carbomer, Disodium EDTA, Methylchloroisothiazolinone, Methylisothiazolinone, Triethanolamine, FD&C Blue No.1

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76176-22276176-222-24

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
NameUNIIKind
CAMPHOR (SYNTHETIC)5TJD82A1ETIACT
FD&C BLUE NO. 1H3R47K3TBDIACT
TRIETHANOLAMINE BENZOATEM3EN4GC19WIACT
WATER059QF0KO0RIACT
ISOPROPYL ALCOHOLND2M416302IACT
CARBOMER 934Z135WT9208IACT
MENTHOLL7T10EIP3AACTIB
METHYLCHLOROISOTHIAZOLINONEDEL7T5QRPNIACT
METHYLISOTHIAZOLINONE229D0E1QFAIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7b8ee331-4847-f0bf-e053-2991aa0a13ea7b8ee331-4846-f0bf-e053-2991aa0a13ea2018-11-01WarningsExact identifier
spl id: 7b8ee331-4847-f0bf-e053-2991aa0a13ea
spl set id: 7b8ee331-4846-f0bf-e053-2991aa0a13ea

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.